IACP News Roundup - September 29, 2017

To keep you informed on all of IACP  member-driven initiatives  and latest legislative & regulatory updates, IACP has debuted a weekly  News Roundup ! Check out this week's report below, and email us at  [email protected]   with questions.

ABOUT

EVP Tracker
  • IACP wants you to have access to the EVP, the staff, as well as the Board of Directors. Stay up-to-date on where IACP's Executive Vice President Cynthia Blankenship, Esq. is traveling, and set-up meetings or come by and say hi! Keep up-to-date on Cynthia's whereabouts with the EVP Tracker and let her know if you would like to host a townhall or meeting at your pharmacy! 
Next on Cynthia's speaking engagement list:
  • United States Pharmacopeia (USP) Compounding Expert Committee (CEC), April 2018
* IACP EVP Cynthia Blankenship has been appointed as the United States Pharmacopeia (USP) delegate representing IACP. The delegate is invited to attend the USP five-year meeting in 2020 and the twice per year Compounding Expert Committee (CEC) meeting as an observer. 

Member Initiatives
  • IACP Initiatives - A Progress Report Card! Keep tuning in to IACP's Executive Vice President (EVP) Cynthia Blankenship's Member Initiatives to see where we're making progress and what we're checking off the list! You asked IACP for several key changes - and we're making them! IACP is in the midst of reviewing & revitalizing ALL of our current programs. We want to ensure we're completely in tune with our membership, providing you with what you need. Do you have suggestions or questions? Please email [email protected]. 
IACP Call for Board of Directors Nominations
  • Call for IACP Board of Directors Nominations! IACP's Call for Nominations and the Election Cycle for the Board of Directors are now open! IACP needs YOU! YOU are instrumental to the success of IACP and to compounding. Please consider joining the IACP Board of Directors, today! The Bylaws of IACP set forth an open election process with nominations for candidates accepted directly from the membership. This year, there are seven Board of Directors' seats including the position of IACP Vice President available. Obtain more detailed information, including candidate eligibility and term length for each board position, and a Nomination Form! Nominations are due by October 12, 2017! 
NEWSROOM

Member Alerts
Member Newsletter
Media


 
News Story Features HR 2871 Sponsor Congressman Morgan Griffith (VA)
 
WDBJ-7 (Roanoke, VA) Griffith Compounding Bill Draws Criticism, September 22, 2017
 
Excerpt : "Griffith's legislation would allow compounding pharmacies to prepare drugs for use in a doctor's office without requiring a prescription, written in advance for a specific individual.

He says that's needed, especially in rural areas, to make sure critical drugs are available on short notice. 

Griffith says his proposal doesn't roll back the legislation that was passed after the meningitis outbreak. He says it responds to a change in an FDA rule that could cause problems for rural communities.

"'And if we don't change things, what's going to happen is there's going to be an emergency situation in a rural area," Griffith said, "and we're going to have somebody who loses sight in one eye, or loses an eye because the drugs aren't there.'"

  • Pinksheet: (subscription required) - FDA Considers Compounding Pharmacy Regulations, Sept. 27, 2017
  • Inside Health Policy (subscription required) - Drug Industry Attorney: FDA Quietly Announced It Will Not Implement DQSA, Violated APA, Sept. 20, 2017
  • Drug Topics: FDA Considers Compounding Pharmacy Regulations , Sept.19, 2017
  • Inside Health Policy (subscription required) - FDA to Allow Certain Office-Use Compounding, In Exchange For GMP Oversight, Sept. 18, 2017 
  • Reuters: FDA Plans New Compounding Pharmacy Policy, Agency Head Says, Sept. 15, 2017

MEMBERSHIP

Membership Survey
  • IACP's Membership Survey is Out! IACP is seeking your input on our programs, services, products, and demographics about your practice. IACP values our members and your feedback! We will use YOUR feedback to shape not only the direction of IACP, but also the resources IACP provides, our communications to you, and our events!  IACP Members: Click here to complete the survey. IACP will be keeping in touch with you and regularly engaging your opinions. And, most importantly, communicating back to you the changes we're making based on your opinions.
Membership Drive
  • IACP Extends Membership Drive! Sign Up your Staff for 25% off NEW IACP Memberships. Share this with Your Colleagues! Due to the incredible number of members to join IACP during the membership drive and the interest expressed, IACP has extended our membership drive! Use code CCH25, and click here to save! 
ADVOCACY

Federal Advocacy
  • IACP along with the DQSA Coalition hosted a Congressional Briefing at the Rayburn U.S. House of Representatives Office Building in Washington, D.C. The Objective: to continue educating on the vital need to support patient safety and access to life-saving medications. The panel urged Members of Congress to cosponsor HR 2871: The Preserving Patient Access to Compounded Medications Act of 2017, the bipartisan legislation introduced by Congressmen Morgan Griffith (VA) and Henry Cuellar (TX). The panel shared patients' stories, urged Congress to preserve patient access to vital compounded medications, and discussed the importance of implementing the Drug Quality & Security Act as Congress fully intended. We were thrilled to host Members of Congress, staff and Capitol Hill-based media reporters, and provided an HR 2871 briefing and information packet (background documents and supporting documents) to all attendees. More information here. IACP Members -  you are encouraged to use these background & supporting documents as you educate your stakeholders on HR 2871!
  • Your Efforts are Making a Difference! We Now Have 33 HR 2871 Cosponsors! Has Your Representative Signed On? Please send a direct communication to your Member of Congress. HR 2871 will help clarify the Drug Quality & Security Act (DQSA) in a way that will better align the statute with congressional intent and most importantly, better balance public safety and patient access. Act, Today!
State Advocacy
  • IACP provides our members with a weekly state tracking report - including legislative and regulatory updates! Check out this week's Compounders Stateside report here - you will need to log-in to view this members-only report.  
  • California - California Council for the Advancement of Pharmacy Third Annual CE & Networking Event, Sunday, Oct. 7 & 8, 2017.  
  • Florida - IACP Submits Comments to Florida State Board of Pharmacy. 
  • USP General Chapter <800> State Adoption Status Chart. NASPA has developed a chart providing each state's current adoption status of USP's General Chapter <800>. Thank you, IACP Affiliate NASPA, for developing this invaluable tool!
  • Coming Soon! You've asked for it, and we've got it! IACP is providing our Members-only with a comprehensive, updated, state-by-state Office-Use Compounding Resource! Stay tuned for its debut next week!
Grassroots
  • Grassroots Advocacy - Tell Your Patients and Providers to sign up for the Partnership for Personalized Prescriptions P3 Patient Advocacy Website! Patient Advocacy efforts make a real difference. That's why we need our IACP members' help to encourage more people to Join P3 and to Share their Stories! So many of our own IACP members have joined the P3 effort. Share this resource with everyone in your communities - your patients, your providers, your staff, your friends and family.
  • Your Patients and Providers are Asking their Representatives to Support HR 2871 with more than 496 messages sent to the Hill! Encourage your patients and providers to visit P3's Patient Advocacy Website. Advocates can instantly send a direct message to their Congressional Representatives, asking them to cosponsor the bipartisan legislation, HR 2871. Visit P3's Patient Advocacy Website. It's easy to use and will only take a few minutes to send an important HR 2871 message to Congress.
  • IACP MEMBERS: We NEED your patient stories to feature on the P3 website - how have compounded medications helped your community? Please email Dagmar Anderson Climo, VP of IACP Communications at [email protected].